Condition
Atherogenic Dyslipidemia
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed4
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05001126Not ApplicableCompleted
The Dose-response Effects of High Intensity Functional Training on Metabolic Syndrome Risk Factors
NCT03615534Phase 4CompletedPrimary
Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females
NCT04209816Enrolling By Invitation
Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
NCT00852267Not ApplicableCompleted
Lipoprotein Effects of Substituting Beef Protein for Carbohydrate
NCT01027325Not ApplicableCompleted
Resistant Starch Insulin Sensitivity Trial
Showing all 5 trials